Experimental and Numerical Integrated Strategy for the Optimization of Microfluidic Parameters for Eudragit L100 Nanoparticles and Microparticles
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Alessia Giglio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Sciences, University of Pavia, V.le Taramelli 12, Pavia 27100, Italy. Hauptthemen laut MEDLINE: Nanoparticles, Polymethacrylic Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: European Commission, European Regional Development Fund.
Abstract (Originalsprache)
Oral immunization offers a minimally invasive administration, inducing local and systemic immune responses and facilitating mass immunization without needle-related risks. However, the gastrointestinal environment poses challenges, compromising vaccine effectiveness through enzymatic degradation and poor absorption by Peyer's patches. Advances in nanoparticle and microparticle (NP/MP) technology protect vaccines from degradation and enhance targeted release. The aim of this study was to develop pH-controlled polymeric carriers for the oral delivery of protein vaccines in order to target the antigen-presenting cells and M cells in the region of Peyer's patches. Here, myoglobin was chosen as a model protein vaccine. This study focuses on Eudragit L100, a pH-responsive polymer stable in acidic conditions and dissolving at higher pH, to develop carriers for controlled myoglobin release in the intestinal tract. A microfluidic-based manufacturing process for Eudragit L100 NPs and MPs is optimized using a comprehensive experimental and computational approach to obtain NPs and MPs through the same setup. Integrating in silico and experimental methods highlights the potential of numerical simulations to streamline final product development. This approach improves the efficiency and cost-effectiveness of NP/MP production, demonstrating how the combination of design of experiment and numerical simulations can optimize production parameters and refine manufacturing processes for advanced drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Sciences, University of Pavia, V.le Taramelli 12, Pavia 27100, Italy.
- Department of Civil Engineering and Architecture, Via Ferrata 3, Pavia 27100, Italy.
ORCID-Profile: Bice Conti, Ida Genta, Enrica Chiesa
Förderung
- European Commission
- European Regional Development Fund
Zitieren
APA
Giglio, A., Bellotti, M., Conti, B., E-Hasnat, N., Auricchio, F., Genta, I., Caimi, A., & Chiesa, E. (2024). Experimental and Numerical Integrated Strategy for the Optimization of Microfluidic Parameters for Eudragit L100 Nanoparticles and Microparticles. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00869
Vancouver
Giglio A, Bellotti M, Conti B, E-Hasnat N, Auricchio F, Genta I, et al. Experimental and Numerical Integrated Strategy for the Optimization of Microfluidic Parameters for Eudragit L100 Nanoparticles and Microparticles. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00869
BibTeX
@article{Giglio2024,
author = {Giglio, Alessia and Bellotti, Marco and Conti, Bice and E-Hasnat, Nur and Auricchio, Ferdinando and Genta, Ida and Caimi, Alessandro and Chiesa, Enrica},
title = {Experimental and Numerical Integrated Strategy for the Optimization of Microfluidic Parameters for Eudragit L100 Nanoparticles and Microparticles},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00869}
}
EUVIMED